美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）
检索条件:" 注册申请号=NDA203684"
符合检索条件的记录共 4 条，共 1 页，当前第 1 页 ，可点击列名称排序
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
0270-7099-73 0270-7099 HUMAN PRESCRIPTION DRUG LumaSon SULFUR HEXAFLUORIDE KIT 20200115 N/A NDA NDA203684 BRACCO DIAGNOSTICS INC 5 KIT in 1 BOX (0270-7099-73) / 1 KIT in 1 KIT * 25 mg in 1 VIAL * 5 mL in 1 SYRINGE
0270-7099-16 0270-7099 HUMAN PRESCRIPTION DRUG LumaSon SULFUR HEXAFLUORIDE KIT 20150115 N/A NDA NDA203684 BRACCO DIAGNOSTICS INC 5 KIT in 1 BOX (0270-7099-16) / 1 KIT in 1 KIT * 25 mg in 1 VIAL * 5 mL in 1 SYRINGE
0270-7097-07 0270-7097 HUMAN PRESCRIPTION DRUG LumaSon SULFUR HEXAFLUORIDE INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION INTRAVENOUS; INTRAVESICAL 20210401 N/A NDA NDA203684 BRACCO DIAGNOSTICS INC DISTEAROYLPHOSPHATIDYLCHOLINE, DL-; SODIUM 1,2-DIPALMITOYL-SN-GLYCERO-3-PHOSPHO-(1'-RAC-GLYCEROL); SULFUR HEXAFLUORIDE .19 mg/mg; .19 mg/mg; 60.7 mg/mg 20 VIAL in 1 BOX (0270-7097-07) / 25 mg in 1 VIAL
0270-7097-08 0270-7097 HUMAN PRESCRIPTION DRUG Lumason SULFUR HEXAFLUORIDE INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION INTRAVENOUS; INTRAVESICAL 20210401 N/A NDA NDA203684 BRACCO DIAGNOSTICS INC DISTEAROYLPHOSPHATIDYLCHOLINE, DL-; SODIUM 1,2-DIPALMITOYL-SN-GLYCERO-3-PHOSPHO-(1'-RAC-GLYCEROL); SULFUR HEXAFLUORIDE .19 mg/mg; .19 mg/mg; 60.7 mg/mg 20 VIAL in 1 BOX (0270-7097-08) / 25 mg in 1 VIAL
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase